Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Adenosquamous × Cyclophosphamide × 30 days × Clear all

Sponsor

Conditions

Multiple Myeloma 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 19 Lymphoma, Large B-Cell, Diffuse 19 Lymphoma 18 Burkitt Lymphoma 18 Lymphoma, Follicular 15 Neoplasms 14 Leukemia, Myeloid, Acute 14 Lymphoma, Non-Hodgkin 13 Leukemia, Lymphocytic, Chronic, B-Cell 13 Breast Neoplasms 12 Recurrence 10 Melanoma 10 Hodgkin Disease 9 Myelodysplastic Syndromes 8 Ovarian Neoplasms 7 Lymphoma, B-Cell, Marginal Zone 7 Lymphoma, B-Cell 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Leukemia, Biphenotypic, Acute 7 Leukemia 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Sarcoma 5 Rhabdomyosarcoma 5 Pancreatic Neoplasms 5 Neoplasm Metastasis 5 Lymphoma, Mantle-Cell 5 Hematologic Neoplasms 5 Sarcoma, Ewing 4 Neuroblastoma 4

Interventions

11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡